Table 1 Clinicopathological features of non-muscle-invasive bladder cancer (NMIBC) cases treated with Bacillus Calmette-Guérin (BCG).

From: Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients

Variables

n (%)

p value

Total

75

 

Age at diagnosis, years (y)

 Median

72

 

Range

42 - 95

0.0223

 ≤65 y

16 (21.3%)

 

 >65 y

59 (78.7%)

 

Gender

 

1

 Male

62 (82.6%)

 

 Female

13 (17.3%)

 

Smoking status

 

0.071

 Yes

50 (66.6%)

 

 No

24(32%)

 

 na

1 (1.4%)

 

BMI

 

0.8307

 Normal weight

36 (49.31%)

 

 Overweight

29 (39.73%)

 

 Obese

8(10.96%)

 

BCG responsiveness

 Responder

28 (37.3%)

 

 Non-responder

47 (62.7%)

 
  1. Statistical significance has been calculated by Fisher’s exact test.
Back to article page